Menstrual Migraine Clinical Trials in Kai, Yamanashi
2 recruitingKai, Yamanashi, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Pfizer723 enrolled122 locationsNCT06641466
Recruiting
Phase 3
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Menstrual Migraine (MM)
AbbVie430 enrolled95 locationsNCT06806293